Search research articles
Contact Us
Filters
Showing results (371-380 of 425) with videos related to
Page
of 43
Sort By:
Bioanalysis
|
June 4, 2015
Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots
Daniel Gonzalez, Chiara Melloni, Brenda B Poindexter, et al.
Antimicrobial Agents and Chemotherapy
|
November 1, 2017
Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children
Julie Autmizguine, Chiara Melloni, Christoph P Hornik, et al.
Journal of Clinical Pharmacology
|
April 21, 2018
Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children
Christoph P Hornik, Daniel Gonzalez, John van den Anker, et al.
Parasite Immunology
|
February 6, 2020
Schistosoma haematobium infection modulates Plasmodium falciparum parasite density and antimalarial antibody responses
Léonidas Tokplonou, Odilon Nouatin, Paulin Sonon, et al.
British Journal of Clinical Pharmacology
|
September 3, 2019
Population pharmacokinetics of sildenafil in extremely premature infants
Daniel Gonzalez, Matthew M Laughon, P Brian Smith, et al.
Journal of Clinical Pharmacology
|
May 16, 2019
β<sub>2</sub> -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies
Mohamed H Shahin, Nihal El Rouby, Daniela J Conrado, et al.
Brain : a Journal of Neurology
|
November 29, 2015
Delayed intramuscular human neurotrophin-3 improves recovery in adult and elderly rats after stroke
Denise A Duricki, Thomas H Hutson, Claudia Kathe, et al.
Therapeutic Drug Monitoring
|
November 15, 2012
Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment
Antonio D'Avolio, Alessia Ciancio, Marco Siccardi, et al.
The Pediatric Infectious Disease Journal
|
January 7, 2017
Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age
Daniel Gonzalez, John S Bradley, Jeffrey Blumer, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 16, 2019
Physiologically-Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants
Jacqueline G Gerhart, Kevin M Watt, Andrea Edginton, et al.
Page
of 43
Search research articles
Search
Showing results (371-380 of 425) with videos related to
Sort By:
Page
of 43
Bioanalysis
|
June 4, 2015
Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots
Daniel Gonzalez, Chiara Melloni, Brenda B Poindexter, et al.
Antimicrobial Agents and Chemotherapy
|
November 1, 2017
Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children
Julie Autmizguine, Chiara Melloni, Christoph P Hornik, et al.
Journal of Clinical Pharmacology
|
April 21, 2018
Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children
Christoph P Hornik, Daniel Gonzalez, John van den Anker, et al.
Parasite Immunology
|
February 6, 2020
Schistosoma haematobium infection modulates Plasmodium falciparum parasite density and antimalarial antibody responses
Léonidas Tokplonou, Odilon Nouatin, Paulin Sonon, et al.
British Journal of Clinical Pharmacology
|
September 3, 2019
Population pharmacokinetics of sildenafil in extremely premature infants
Daniel Gonzalez, Matthew M Laughon, P Brian Smith, et al.
Journal of Clinical Pharmacology
|
May 16, 2019
β<sub>2</sub> -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies
Mohamed H Shahin, Nihal El Rouby, Daniela J Conrado, et al.
Brain : a Journal of Neurology
|
November 29, 2015
Delayed intramuscular human neurotrophin-3 improves recovery in adult and elderly rats after stroke
Denise A Duricki, Thomas H Hutson, Claudia Kathe, et al.
Therapeutic Drug Monitoring
|
November 15, 2012
Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment
Antonio D'Avolio, Alessia Ciancio, Marco Siccardi, et al.
The Pediatric Infectious Disease Journal
|
January 7, 2017
Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age
Daniel Gonzalez, John S Bradley, Jeffrey Blumer, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 16, 2019
Physiologically-Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants
Jacqueline G Gerhart, Kevin M Watt, Andrea Edginton, et al.
Page
of 43